Senior Director, CMC Leadership & Diligence, Early Asset Leadership and Evaluation
Bristol Myers Squibb
September 02, 2026
Remote friendly (New Brunswick, NJ)
United States
Operations
Position: Senior Director, CMC Diligence & Leadership
Responsibilities:
- Own CMC diligence strategy for in-licensing, alliances, and M&A; scientific single point of contact with Corporate Business Development across the deal lifecycle.
- Lead cross-functional diligence teams to assess drug substance, drug product, analytical, quality, clinical supply, and regulatory readiness; identify technical risks and value-creation opportunities.
- Drive PDS-related deal negotiations/contracting with Business Development, Legal, and Finance to protect BMS technical and commercial interests.
- Lead COGs estimates and financial-flow modeling with PDS Finance to inform deal structure and pricing.
- Build/present diligence findings, valuations, and risk-mitigation plans to support investment approvals and go/no-go decisions.
- Provide timely, well-reasoned CMC recommendations with partial/incomplete data, clearly flagging residual risk and impact.
- Lead post-transaction integration of acquired/partnered assets into R&D and PDS.
- Develop and execute compound-specific integrated CMC strategies across drug substance, drug product, analytical, quality, regulatory, and clinical supplies.
- Influence/critically review CMC regulatory strategy and submissions (e.g., briefing documents, health authority requests).
- Communicate decision-ready recommendations to C-suite and governance committees.
- Drive CMC budget planning and apply cost/capacity/investment analysis for portfolio strategy and prioritization.
Minimum Qualifications:
- Advanced degree (chemistry, biochemical/chemical engineering, or related); PhD preferred; 15+ years in biopharmaceutical industry.
- Substantial business development/alliance management experience (deal diligence, negotiation support, cross-functional leadership).
- Strong knowledge of BDS/API and/or drug product development/manufacturing across multiple modalities (biologics, small molecules, ADCs).
- Proven track record leading CMC teams and evaluating external assets from early stage through commercialization (CMOs/complex supply chains).
- Exceptional executive presence and communication; ability to present technical/financial recommendations.
- Solid understanding of CMC integration with Regulatory, Quality, Clinical, Manufacturing, and Commercial; knowledge of FDA/EMA/ICH.
- Ability to make defensible scientific/business decisions with limited/incomplete information.
- High integrity and confidentiality.
- Travel up to 10% domestically/internationally.
Benefits:
- Eligible for comprehensive benefits (wellbeing support, retirement/financial protection, medical/dental/vision/life/disability).
Application:
- Apply through the company careers site; U.S.-based job seekers can view benefits at https://careers.bms.com/benefits
Responsibilities:
- Own CMC diligence strategy for in-licensing, alliances, and M&A; scientific single point of contact with Corporate Business Development across the deal lifecycle.
- Lead cross-functional diligence teams to assess drug substance, drug product, analytical, quality, clinical supply, and regulatory readiness; identify technical risks and value-creation opportunities.
- Drive PDS-related deal negotiations/contracting with Business Development, Legal, and Finance to protect BMS technical and commercial interests.
- Lead COGs estimates and financial-flow modeling with PDS Finance to inform deal structure and pricing.
- Build/present diligence findings, valuations, and risk-mitigation plans to support investment approvals and go/no-go decisions.
- Provide timely, well-reasoned CMC recommendations with partial/incomplete data, clearly flagging residual risk and impact.
- Lead post-transaction integration of acquired/partnered assets into R&D and PDS.
- Develop and execute compound-specific integrated CMC strategies across drug substance, drug product, analytical, quality, regulatory, and clinical supplies.
- Influence/critically review CMC regulatory strategy and submissions (e.g., briefing documents, health authority requests).
- Communicate decision-ready recommendations to C-suite and governance committees.
- Drive CMC budget planning and apply cost/capacity/investment analysis for portfolio strategy and prioritization.
Minimum Qualifications:
- Advanced degree (chemistry, biochemical/chemical engineering, or related); PhD preferred; 15+ years in biopharmaceutical industry.
- Substantial business development/alliance management experience (deal diligence, negotiation support, cross-functional leadership).
- Strong knowledge of BDS/API and/or drug product development/manufacturing across multiple modalities (biologics, small molecules, ADCs).
- Proven track record leading CMC teams and evaluating external assets from early stage through commercialization (CMOs/complex supply chains).
- Exceptional executive presence and communication; ability to present technical/financial recommendations.
- Solid understanding of CMC integration with Regulatory, Quality, Clinical, Manufacturing, and Commercial; knowledge of FDA/EMA/ICH.
- Ability to make defensible scientific/business decisions with limited/incomplete information.
- High integrity and confidentiality.
- Travel up to 10% domestically/internationally.
Benefits:
- Eligible for comprehensive benefits (wellbeing support, retirement/financial protection, medical/dental/vision/life/disability).
Application:
- Apply through the company careers site; U.S.-based job seekers can view benefits at https://careers.bms.com/benefits